Clinical Trial: Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: 18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers&

Brief Summary: This study will evaluate 18F-AV-1451 for brain imaging of tau in subjects with progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and healthy volunteers.

Detailed Summary:
Sponsor: Avid Radiopharmaceuticals

Current Primary Outcome: 18F-AV-1451 imaging in PSP, CBD and Healthy Volunteers [ Time Frame: 75-105 minutes post injection ]

Compare standard uptake value ratio (SUVR) by diagnostic group (PSP, CBD and healthy volunteers).


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Avid Radiopharmaceuticals

Dates:
Date Received: June 17, 2014
Date Started: July 2014
Date Completion:
Last Updated: August 31, 2016
Last Verified: August 2016